Who
Marc A. Began
EVP & General Counsel
Company insider
Files Form 4 as: EVP & General Counsel, Axogen; VP & General Counsel, Abiomed.
In numbers
- Trades disclosed
- 50
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $8.0M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 6 Nov 2020
- Last trade
- 10 Aug 2026
- Last filed
- 12 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 12 Aug 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $551K67,500 at $8.16 | filing |
| 10 Aug 2026filed 12 Aug 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $3.2M67,500 at $47.35 | filing |
| 10 Aug 2026filed 12 Aug 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —67,500 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —67,500 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $551K67,500 at $8.16 | filing |
| 10 Aug 2026filed 12 Aug 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $3.2M67,500 at $47.35 | filing |
| 1 Mar 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —11,250 at $0.00 | filing |
| 1 Mar 2026filed 2 Mar 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —11,250 at $0.00 | filing |
| 1 Mar 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $136K4,427 at $30.65 | filing |
| 1 Mar 2026filed 2 Mar 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —11,250 at $0.00 | filing |
| 1 Mar 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —11,250 at $0.00 | filing |
| 1 Mar 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $136K4,427 at $30.65 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code A | —33,780 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $279K8,753 at $31.90 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —23,000 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —23,000 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code A | —33,780 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code F | $279K8,753 at $31.90 | filing |
| 11 Dec 2025filed 12 Dec 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $397K13,222 at $30.00 | filing |
| 9 Dec 2025filed 10 Dec 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $290K9,278 at $31.21 | filing |
News
Analyzing AxoGen (NASDAQ:AXGN) & RxSight (NASDAQ:RXST)AXGN · themarketsdaily.com · 22 Oct 2026Analyzing GE HealthCare Technologies (NASDAQ:GEHC) & AxoGen (NASDAQ:AXGN)AXGN · tickerreport.com · 21 Oct 2026Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)AXGN · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Marc A. Began; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.